Best GLP-1 tracking apps in 2026 — ranked, reviewed, honest
title: "Best GLP-1 tracking apps in 2026 — ranked, reviewed, honest" description: "Independent comparison of the leading GLP-1 medication tracking apps for 2026. Includes Titra alongside competitors, with honest assessment of who each is for." publishedAt: "2026-04-26" cluster: "glp1" faqs:
- question: "Which GLP-1 tracking app is best in 2026?" answer: "It depends on what you want from it. For private, no-account, no-social-feed tracking with smart injection rotation — Titra. For community-driven peer accountability — Shotsy. For nutrition-led tracking with a doctor in the loop — Found or Sequence's app. There is no single best; pick by what trade-off you want."
- question: "Are GLP-1 tracking apps regulated?" answer: "Most are not classified as medical devices in the US, UK, or EU because they don't diagnose, treat, or prescribe. They are wellness software. That's a deliberate design choice — it keeps the apps usable without prescription verification, but it also means they cannot legally claim clinical outcomes."
- question: "Is my data private if I use a GLP-1 app?" answer: "Varies wildly. Some apps store data only on your device. Others sync to the cloud and share anonymised data with research partners. Others share data with telehealth or pharma partners. Read each app's privacy policy and subprocessor list before installing."
- question: "Can I share my GLP-1 tracking data with my doctor?" answer: "Most apps support PDF export or summary reports. Quality varies. Some apps generate a one-page appointment summary; others export raw data dumps that need interpretation."
- question: "Do I need an app at all?" answer: "If your dose is stable, your side effects are predictable, and your weight is on a steady curve, probably not. Apps earn their keep when you're titrating up, when side effects are unpredictable, or when you have multiple data points (protein, water, activity) you want to track alongside the medication."
Why this list exists
GLP-1 prescriptions roughly tripled between 2023 and 2026. The tracking app category went from a handful of side projects to a real market. Most of the comparison content out there is affiliate-funded SEO sludge that ranks every app 4.7 stars and tells you nothing useful.
This is an honest comparison. We make one of these apps (Titra), and we'll tell you exactly when to pick a competitor instead.
The criteria
We ranked on five factors:
- Privacy posture — local-only, cloud-sync, or sharing with third parties?
- Tracking quality — does it capture the things that actually matter (dose, weight, side effects, injection sites, protein, water) without making logging a chore?
- Insights — does it tell you anything useful, or just store your data?
- Honest about what it isn't — clinical advice? Community accountability? Doctor in the loop?
- Price — free, freemium, or subscription?
The ranking
1. Titra — best for private, no-fuss tracking
Best for: People who want their tracker to be a tracker — not a community, not a coach, not a feed.
Titra is our own product, so usual disclaimer applies. The design choices are deliberate.
What it does well:
- Local-only data by default. Free tier never touches the cloud. titra+ subscribers can opt into encrypted cloud backup.
- Smart 14-site injection rotation with distance + pain + recency scoring. This is the feature people DM us about.
- Privacy-first reminders — notification mode hides the medication name on your lock screen.
- Side-effect tracking with pattern detection across 20+ symptoms.
- Anonymous community benchmarks ("you're ahead of 71% of people on your dose") with differential privacy. No usernames, no posts, no leaderboards.
- titra+ generates an appointment-ready PDF for your prescriber.
Where it loses:
- No community feed, no accountability buddy, no coaching. By design — but if that's what you want, this isn't your app.
- iOS is in App Store review as of April 2026 (Android is live). If you're an iPhone user with no patience, pick something else for now.
- No doctor-in-the-loop integration. Titra is a tracker, not a telehealth product.
Pricing: Free tier is fully functional. titra+ is $4.99/month or $39.99/year (7-day trial). Available in 175 countries.
Pick this if: You want to track your medication, see your patterns, and never get a notification asking how you're feeling.
2. Shotsy — best for community-driven accountability
Best for: People who do better when they share their progress.
Shotsy has a strong, active community and good streak mechanics. If you're motivated by seeing other people's journeys, this is the app.
What it does well:
- Active community feed with high engagement
- Streak tracking and gamification done well
- Dose logging is fast and the UI is friendly
- Public progress sharing (opt-in)
Where it loses:
- Privacy posture is "share by default, opt out for private" — the opposite of Titra's stance
- Community feed can be triggering for users with eating disorder history (Shotsy's content moderation is decent but not airtight)
- Less depth on side effect tracking, injection rotation
Pricing: Freemium with subscription for advanced features.
Pick this if: You want peer accountability and are happy sharing your progress publicly.
3. Found — best for doctor-in-the-loop care
Best for: People who want their tracker connected to a prescriber.
Found is a telehealth product first, tracker second. If you don't have a prescriber yet, or if your existing prescriber is hard to reach, the integrated care model is genuinely useful.
What it does well:
- Telehealth visits with clinicians who specialise in GLP-1 care
- Prescription logistics handled (compounded options where legally available)
- Tracking integrated with care plan
- Weight-loss-coach support included in higher tiers
Where it loses:
- It's a care subscription, not just an app — much higher price
- Compounded GLP-1 availability has shifted under FDA enforcement; check current status
- Lock-in: leaving Found means leaving your prescriber
Pricing: Subscription, $99–$199/month range depending on tier and what's included.
Pick this if: You want one bill that covers prescription, doctor visits, and tracking.
4. Sequence (now WeightWatchers Clinic) — best for behaviour-led tracking
Best for: People who want GLP-1 medication paired with structured behaviour change.
Sequence (rebranded after the WW acquisition) leans heavily on the behaviour-change side. If you want a coach asking you about your protein intake every day, this is the app.
What it does well:
- Strong behavioural support and coach access
- Nutrition tracking is excellent (inherited from WW)
- Doctor-in-the-loop available
Where it loses:
- Heavy daily commitment — not for users who want lightweight tracking
- Subscription pricing is significant
- Brand baggage from WW will be a feature or a bug depending on how you feel about WW
Pricing: Subscription, $79–$199/month.
Pick this if: You want medication and behaviour-change support bundled.
5. Mounjaro Companion — best for pharma-tier polish
Best for: People who specifically want a tool from the medication's manufacturer.
Eli Lilly's official Mounjaro tracking app is well-built and has the credibility of being made by the people who make the drug. The trade-off is that it's exclusively for tirzepatide users.
What it does well:
- Clean, polished UI
- Direct connection to Lilly's patient support resources
- Reliable for the specific use case
Where it loses:
- Locked to one medication — switch to semaglutide and the app is useless
- Limited differentiation if you're not a Mounjaro patient
- Less innovative than independent apps (pharma moves slowly on UX)
Pricing: Free.
Pick this if: You're on Mounjaro and you trust pharma-issued tools more than independent ones.
The decision tree
| If you want... | Pick |
|---|---|
| Privacy-first, no-account tracking | Titra |
| Community and accountability | Shotsy |
| Doctor + prescription + tracking in one bundle | Found |
| Medication + behaviour change coaching | Sequence |
| Pharma-issued tool for Mounjaro specifically | Mounjaro Companion |
What none of these do well (yet)
Worth flagging:
- Multi-medication switching is hard. None of these handle the "I went from Wegovy to Mounjaro three months in" path well. Data continuity breaks.
- Real-world dose escalation analytics are still thin. Pharma trial data is 16-week focused; the apps are starting to publish 52+ week curves but the cohorts are small.
- Insurance integration is non-existent. Tracking your prior auth journey would be valuable. Nobody does it.
- Side-effect prediction is correlation, not causation. Anyone telling you they'll "predict" your side effects in 2026 is selling you a confidence-weighted average, not an oracle.
What's next
If this was useful, the GLP-1 cluster on AgentM Insights publishes weekly: /insights/glp1/. Or download Titra to try the privacy-first approach: Titra on Google Play. iOS coming.
A note on safety
GLP-1 medications have a meaningful side-effect profile. The five FDA safety warnings (medullary thyroid carcinoma risk, acute pancreatitis, aspiration risk during anaesthesia, gallbladder disease, ileus) apply across the class. No tracking app replaces a prescriber. If you are experiencing severe side effects, contact your healthcare provider.
Disclosure: Titra is a product made by AgentM. We've tried to be honest about where competitors win. If you spot something inaccurate, tell us — we'll update.